NCT04536909 (INTRAKS) is a clinical trial of Non-surgical in Kyphoscoliosis, sponsored by University of Bergen.

Who is sponsoring NCT04536909?

NCT04536909 is sponsored by University of Bergen.

What drugs are being tested in NCT04536909?

Interventions in NCT04536909: Non-surgical, Surgical.

What condition does NCT04536909 study?

NCT04536909 studies Kyphoscoliosis.

Is NCT04536909 still recruiting?

NCT04536909 is currently active, enrolled. Last updated 19 September 2024.

Last reviewed 2024-09-19 · How we verify

NCT04536909: INTRAKS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Indication and Treatment of Adult Kyphoscoliosis

Active, enrolled Last updated 19 September 2024

What this trial tests

trial testing Non-surgical in Kyphoscoliosis in 120 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

1 January 2020

Primary endpoint
1 January 2024

1 January 2026

Quick facts

Lead sponsor	University of Bergen
Status	Active, enrolled
Study type	OBSERVATIONAL
Enrollment	120
Start date	1 January 2020
Primary completion	1 January 2024
Estimated completion	1 January 2026
Sites	5 locations across Sweden, Japan, Norway

Drugs / interventions tested

Non-surgical
Surgical

Conditions studied

Kyphoscoliosis — all drugs for Kyphoscoliosis →

Sponsor

University of Bergen

Who can join

25 and older, any sex, with Kyphoscoliosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Degeneration, iatrogenic-/idiopathic causes and fractures can lead to kypho- scoliotic deformities potentially resulting in pain and loss of function. The surgical strategies rely on surgeon preferences and type of deformity as well as clinical symptoms. The complication rate of surgical treatment is high. The aim of this study is to elucidate the indications for surgical treatment of kyphoscoliosis and evaluate the effectiveness of surgical and non-surgical outcome clinically and radiologically. The primary outcome for the PROMs and x-ray is at 12 months, but the investigators will also follow the patients with the PROMs and x-rays after 2,5 and 10 years.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Non-surgical

Trials testing the same drug.

NCT00878319 — Operative and Nonoperative Treatment of Humeral Shaft Fractures · NA · completed

Other University of Bergen trials

Trials by the same sponsor.

NCT07028450 — Effects of Proactive Call to Customers of Norsk Rikstoto (Horse Gambling Operator in Norway): A Randomized Controlled St · NA · not yet recruiting
NCT04602572 — Obesity and Oral Diseases in Adult Patients · not yet recruiting
NCT07460817 — A Brief Intervention for PTSD - BWRT · NA · enrolling by invitation
NCT06960226 — Replication Study: Reducing Pain With Focused Music Listening · NA · completed
NCT07299669 — Effects of BEMER Electromagnetic Field Intervention on Sleep, Readiness to Play and Injuries in Elite Athletes · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04536909 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Bergen
Last refreshed: 19 September 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04536909.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing